Givaudan SA
LSE:0QPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Givaudan SA
LSE:0QPS
|
CH |
|
S
|
Swiss Re AG
F:SR9A
|
CH |
|
D
|
Deutsche Post AG
XBER:DHL
|
DE |
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
|
C
|
Cirrus Logic Inc
XMUN:CRU
|
US |
Wall St Price Targets
0QPS Price Targets Summary
Givaudan SA
According to Wall Street analysts, the average 1-year price target for 0QPS is 3 435.88 CHF with a low forecast of 2 627.85 CHF and a high forecast of 4 728.33 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QPS's stock price target?
Price Target
3 435.88
CHF
According to Wall Street analysts, the average 1-year price target for 0QPS is 3 435.88 CHF with a low forecast of 2 627.85 CHF and a high forecast of 4 728.33 CHF.
What is the Revenue forecast for Givaudan SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 7 years is 4%.
What is the Operating Income forecast for Givaudan SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 7 years is 4%.
What is the Net Income forecast for Givaudan SA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 6%.
